Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Sartorius AG
  6. News
  7. Summary
    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Sartorius' : Nine-Month Profit Soars Almost 93% On Strong Revenue Growth

10/20/2021 | 01:23am EST


ę MT Newswires 2021
All news about SARTORIUS AG
11/26Sartorius to Invest EUR100 Million in France by 2025, Create Up to 400 Jobs
DJ
11/25Sartorius to Invest Around EUR270 Million in South Korea Expansion
DJ
11/24Sartorius Significantly Expands Activities in South Korea
CI
11/18SARTORIUS : Opens Cell Culture Technology Center
PU
11/12SARTORIUS VORZUEGE : DZ Bank reiterates its Neutral rating
MD
11/11SARTORIUS VORZUEGE : Gets a Sell rating from UBS
MD
11/03Sartorius Honored as “Overall Best Bioprocessing Supplier” Award...
PU
11/01Sartorius Introduces Faster, Higher Capacity Sartolab« RF|BT...
PU
10/28SARTORIUS VORZUEGE : Berenberg remains Neutral
MD
10/27Waters and Sartorius Partner to Help Bioprocess Scientists...
PU
More news
Analyst Recommendations on SARTORIUS AG
More recommendations
Financials
Sales 2021 3 394 M 3 830 M 3 830 M
Net income 2021 411 M 464 M 464 M
Net Debt 2021 1 885 M 2 128 M 2 128 M
P/E ratio 2021 86,6x
Yield 2021 0,26%
Capitalization 37 457 M 42 386 M 42 270 M
EV / Sales 2021 11,6x
EV / Sales 2022 10,2x
Nbr of Employees 12 952
Free-Float 35,0%
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | SRT | DE0007165607 | MarketScreener
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 515,00 €
Average target price 483,55 €
Spread / Average Target -6,11%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chief Executive Officer
Rainer Lehmann Chief Financial Officer
Lothar Kappich Chairman-Supervisory Board
Oscar-Werner Reif Head-Research & Development
Volker Niebel Head-Production, Procurement & Business Operations
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS AG49.28%42 386
BIOTAGE AB (PUBL)89.21%1 906
REVENIO GROUP OYJ9.24%1 652
VAREX IMAGING CORPORATION76.68%1 162
CELLAVISION AB (PUBL)15.90%932
908 DEVICES INC.-59.00%651